Suresh S. Ramalingam, MD, FASCO, Winship Cancer Institute of Emory University
Advertisement
Articles by Suresh S. Ramalingam, MD, FASCO, Winship Cancer Institute of Emory University
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma
2
ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC
3
mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC
4
FDA Grants Fast Track Designation to PLN-101095 Plus Pembrolizumab in Solid Tumors
5